Preparation method of tipiracil hydrochloride crystal

During the preparation process of ticipidine hydrochloride, the temperature control and cooling process of water and organic solvents were used to control and cool down the impurity content of TPI-one and 2-IP was successfully reduced, and the purity and quality of ticipidine hydrochloride in the prior art were solved. The problem of difficulty in ensuring high purity and high yield preparation is achieved, and is suitable for commercial production.

CN119019372APending Publication Date: 2024-11-26SUZHOU KELUN PHARMA RES CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202310584757.9
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2023-05-23
Publication Date
2024-11-26

AI Technical Summary

Technical Problem

The prior art cannot effectively control the content of the specific impurities TPI-one and 2-IP in ticipyrimidine hydrochloride crystal I, resulting in difficulty in ensuring the purity and quality of the drug, affecting the therapeutic effect and safety.

Method used

By heating and stirring the crude tippyrimidine hydrochloride in water, adding organic solvents to control the temperature and cooling them in stages, adding tippyrimidine hydrochloride seed crystals, insulated and stirred, and finally filtering and drying to obtain high-purity tippyrimidine hydrochloride crystals, ensuring that The impurity content is at very low levels.

Benefits of technology

It effectively reduces the content of TPI-one and 2-IP, improves the purity and product quality of tipipyrimidine hydrochloride crystals, has a stable process and high yield, and is suitable for commercial production.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004242870890000011
    Figure BDA0004242870890000011
Patent Text Reader

Abstract

The invention provides a preparation method of a tipiracil hydrochloride crystal, and belongs to the technical field of medicines. Specifically, the preparation method of the tipiracil hydrochloride crystal comprises the following steps: adding a tipiracil hydrochloride crude product into water, heating, stirring and dissolving, controlling the temperature, adding a certain amount of an organic solvent, carrying out programmed cooling in three stages, adding a tipiracil hydrochloride seed crystal after the programmed cooling in the first stage, carrying out heat preservation and stirring, and carrying out cooling in the second stage, so as to obtain the tipiracil hydrochloride crystal. And cooling to a certain temperature in the second and third stages, preserving heat, stirring, filtering and drying to obtain the tipiracil hydrochloride crystal. The preparation method is high in yield, and the obtained tipiracil hydrochloride crystal is high in purity, low in key specific impurity content, good in product quality and suitable for drug development requirements.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of drug preparation, and particularly relates to a method for preparing tipiracil hydrochloride crystals. Background Art

[0002] TAS-102 is a novel oral nucleoside anti-tumor combination drug developed by Taiho Pharmaceutical Co., Ltd. of Japan for the treatment of advanced metastatic colorectal cancer. TAS-102 contains Trifluridine (FTD) and Tipiracil hydrochloride (TPI), with a molar ratio of 1.0:0.5, and the structural formula is as follows:

[0003]

[0004] Among them, tipiracil hydrochloride can inhibit thymidine phosphorylase involved in the degradation of trifluridine in the human body, and has the effect of enhancing the anti-tumor effect of trifluridine. Its product quality directly affects the therapeutic effect of the drug TAS-102. It is common knowledge in the field that there are two important indicators for drug quality control. One is the purity of the drug. The content of the active ingredient is an important indicator of the purity of the drug. The second is the impurity limit of the drug. The impurities present in the drug will also directly affect the efficacy of the drug and may cause toxic side effects. The main degradation impurity produced during the preparation process of tipiracil hydrochloride is 5-chloro-6-[(2-oxo-1-pyrrolidinyl)methyl]-2,,4(1H,3H)-pyrimidinedione (TPI-ketone, chemical structure ) and 2-aminopyrrolidine hydrochloride (2-IP, chemical structure ), the content limits of these two specific impurities, TPI-ketone and 2-IP, are key indicators for controlling drug quality and need to be monitored during the preparation process.

[0005] There are three crystal forms of tipiracil hydrochloride (crystal I, crystal II, crystal III). Considering the stability, residual solvent, and electric charge of the three crystal forms, crystal I is more suitable for the preparation of drugs related to tipiracil hydrochloride. The purification methods disclosed in the prior art are unable to effectively control the two key specific impurities IPI-ketone and 2-IP of tipiracil hydrochloride crystal I, and are unable to ensure the product quality of the purified tipiracil hydrochloride crystal.

[0006] Therefore, it is of great practical significance to develop a method for preparing tipiramidine hydrochloride with stable process, high yield and low specific impurity content. Summary of the invention

[0007] In view of the shortcomings of the prior art, the present invention aims to provide a method for preparing tepizine hydrochloride crystals with stable process, high yield and low content of specific key impurities.

[0008] To achieve the above purpose, the technical solution adopted by the present invention is as follows:

[0009] The first aspect of the present invention provides a method for preparing tipiracil hydrochloride crystals, the method comprising the following steps:

[0010] (1) adding crude tipiracil hydrochloride to water, heating and stirring the water to dissolve;

[0011] (2) controlling the temperature, adding a certain amount of organic solvent, and then cooling in three stages, and keeping the temperature and stirring after cooling to a certain temperature in each stage;

[0012] (3) Filter and dry the filter cake to obtain tipiracil hydrochloride crystals.

[0013] In some embodiments of the present invention, the dissolution temperature in the step (1) of heating and stirring in water is 40-55°C, preferably 45-50°C, and more preferably 46°C, 47°C or 48°C.

[0014] In some embodiments of the present invention, the organic solvent in step (2) is selected from alcohol solvents such as isopropanol, ethanol, methanol and mixtures thereof, preferably isopropanol and ethanol. Further, the weight ratio of the organic solvent added in step (2) to the water in step (1) is 1:(1-5), preferably 1:(2-4), and more preferably 1:2, 1:2.4, 1:3.8.

[0015] In some embodiments of the present invention, the cooling rate of the three-stage programmed cooling is 5-10° C. / h.

[0016] In some embodiments of the present invention, after the first stage of program cooling, tipiracil hydrochloride seed crystals are added, and the mixture is kept warm and stirred. Further, the first stage of program cooling is to 35-50°C, preferably 40-45°C, more preferably 40°C, 42°C or 43°C, and the stirring time after adding the seed crystals is 1-2h, preferably 1h, 1.5h or 2h.

[0017] In some embodiments of the present invention, the second stage procedure cools down to 20-40°C, preferably 30-35°C, more preferably 30°C, 31°C, 32°C or 33°C, and stirs at this temperature for 3-4h, preferably 3h or 4h.

[0018] In some embodiments of the present invention, the third stage procedure is to cool the mixture to 0-10°C, preferably 0-5°C, more preferably 3°C, 4°C or 5°C, and stir the mixture for 3-5h, preferably 3.5h, 4h or 5h.

[0019] In some embodiments of the present invention, the TPI-ketone impurity content in the tipiracil hydrochloride crystals obtained by filtration and drying is not higher than 0.15%, preferably the TPI-ketone impurity content is not higher than 0.1%, more preferably the TPI-ketone impurity content is not higher than 0.05%, further preferably the TPI-ketone impurity content is not higher than 0.02%, further preferably the TPI-ketone impurity content is not higher than 0.01%, further preferably the TPI-ketone impurity content is not higher than 0.002%.

[0020] In some embodiments of the present invention, the 2-IP impurity content in the tipiracil hydrochloride crystals obtained by filtration and drying is not higher than 0.02%, preferably the 2-IP impurity content is not higher than 0.01%, more preferably the 2-IP impurity content is not higher than 0.005%, and further preferably the 2-IP impurity content is not higher than 0.003%.

[0021] In some embodiments of the present invention, the tepizine hydrochloride crystals obtained by filtration and drying are Form I.

[0022] The second aspect of the present invention provides a method for reducing the content of related impurities in tipiracil hydrochloride crystals, the method comprising the following steps:

[0023] (1) adding crude tipiracil hydrochloride to water, heating and stirring the water to dissolve;

[0024] (2) controlling the temperature, adding a certain amount of organic solvent, and then cooling in three stages, and keeping the temperature and stirring after cooling to a certain temperature in each stage;

[0025] (3) Filter and dry the filter cake to obtain tipiracil hydrochloride crystals.

[0026] In some embodiments of the present invention, the related impurities are selected from one or two of TPI-ketone and 2-IP, and preferred related impurities are TPI-ketone and 2-IP.

[0027] In some embodiments of the present invention, the TPI-ketone impurity content in the tipiracil hydrochloride crystals obtained in step (3) is not higher than 0.15%, preferably the TPI-ketone impurity content is not higher than 0.1%, more preferably the TPI-ketone impurity content is not higher than 0.05%, further preferably the TPI-ketone impurity content is not higher than 0.02%, further preferably the TPI-ketone impurity content is not higher than 0.01%, further preferably the TPI-ketone impurity content is not higher than 0.002%.

[0028] In some embodiments of the present invention, the 2-IP impurity content in the tipiracil hydrochloride crystals obtained in step (3) is not higher than 0.02%, preferably the 2-IP impurity content is not higher than 0.01%, more preferably the 2-IP impurity content is not higher than 0.005%, and further preferably the 2-IP impurity content is not higher than 0.003%.

[0029] In some embodiments of the present invention, the dissolution temperature in the step (1) of heating and stirring in water is 40-55°C, preferably 45-50°C, and more preferably 46°C, 47°C or 48°C.

[0030] In some embodiments of the present invention, the organic solvent in step (2) is selected from alcohol solvents such as isopropanol, ethanol, methanol and mixtures thereof, preferably isopropanol and ethanol. Further, the weight ratio of the organic solvent added in step (2) to the water in step (1) is 1:(1-5), preferably 1:(2-4), and more preferably 1:2, 1:2.4, 1:3.8.

[0031] In some embodiments of the present invention, the cooling rate of the three-stage programmed cooling is 5-10° C. / h.

[0032] In some embodiments of the present invention, after the first stage of program cooling, tipiracil hydrochloride seed crystals are added, and the mixture is kept warm and stirred. Further, the first stage of program cooling is to 35-50°C, preferably 40-45°C, more preferably 40°C, 42°C or 43°C, and the stirring time after adding the seed crystals is 1-2h, preferably 1h, 1.5h or 2h.

[0033] In some embodiments of the present invention, the second stage procedure cools down to 20-40°C, preferably 30-35°C, more preferably 30°C, 31°C, 32°C or 33°C, and stirs at this temperature for 3-4h, preferably 3h or 4h.

[0034] In some embodiments of the present invention, the third stage procedure is to cool the mixture to 0-10°C, preferably 0-5°C, more preferably 3°C, 4°C or 5°C, and stir the mixture for 3-5h, preferably 3.5h, 4h or 5h.

[0035] In some embodiments of the present invention, the tepizine hydrochloride crystals obtained by filtration and drying are Form I.

[0036] In some embodiments of the present invention, the TPI-ketone impurity content in the crude tipiracil hydrochloride product of step (1) is higher than 0.15%, preferably higher than 0.2%, and more preferably 0.21%.

[0037] In some embodiments of the present invention, the 2-IP impurity content in the crude tipiracil hydrochloride product of step (1) is higher than 0.05%, preferably higher than 0.1%, and more preferably 0.15%.

[0038] Compared with the prior art, the present invention has the following beneficial effects:

[0039] 1. The preparation method of the present invention can effectively reduce the content of specific impurities TPI-ketone and 2-IP, and the prepared crystals of tipiracil hydrochloride have high purity and extremely low impurity content, thereby effectively improving the product quality.

[0040] 2. The preparation method of the present invention has stable process, high yield, high product quality, simple operation, low production cost, is suitable for commercial production, and has broad industrial application prospects. DETAILED DESCRIPTION

[0041] In order to make the purpose, technical scheme and advantages of the embodiments of the present invention clearer, the technical scheme in the embodiments of the present invention will be described clearly and completely below. If the specific conditions are not specified in the embodiments, they are carried out under conventional conditions or conditions recommended by the manufacturer. The reagents or instruments used without indicating the manufacturer are all conventional products that can be purchased commercially. Unless otherwise specified, the impurity TPI-ketone content in the crude product of tepiridin hydrochloride used in the embodiments of the present invention is 0.21%, and the impurity 2-IP content is 0.15%.

[0042] The content of the key specific impurities TPI-ketone and 2-IP in the tipiracil hydrochloride crystals prepared in the embodiment of the present invention is determined by high performance liquid chromatography, and the specific detection method is as follows:

[0043] High performance liquid chromatograph: Agilent 1260;

[0044] Chromatographic column: Reverse phase chromatography column with octadecylsilane bond and silica gel as filler (Inertsil ODS-3C18, 4.6mm×150mm, 5μm or chromatographic column with equivalent performance;

[0045] Mobile phase: Mobile phase A: 0.01 mol / L sodium dihydrogen phosphate solution containing 1 g / L sodium heptane sulfonate (take 1.56 g of sodium dihydrogen phosphate·dihydrate and 1.0 g of sodium heptane sulfonate, add 1 L of water to dissolve, shake well, and adjust the pH value to 2.7 with phosphoric acid); Mobile phase B: methanol; Gradient elution program is as follows:

[0046] Time (min) Mobile phase A (%) Mobile phase B (%) 0 95 5 10 95 5 70 65 35 70.1 95 5 80 95 5

[0047] Detection limit: Calculated based on the concentration of 1 mg / ml of tipiracil hydrochloride in the test solution, the detection limit of the impurity TPI-ketone is 0.01912 μg / ml, equivalent to 0.002% of the test solution concentration; the detection limit of the impurity 2-IP is 0.02905 μg / ml, equivalent to 0.003% of the test solution concentration.

[0048] Experimental Example 1

[0049] To a 1L reaction bottle, add 295g of purified water and 73g of crude tipiracil hydrochloride, heat to 47°C, stir to dissolve, add 148g of ethanol, cool to 42°C at a first-stage cooling rate of 5-10°C / h, add tipiracil hydrochloride seed crystals, keep warm and stir for 1.5h, cool to 30°C at a second-stage cooling rate of 5-10°C / h, keep warm and stir for 3h, cool to 4°C at a third-stage cooling rate of 5-10°C / h, keep warm and stir for 4h, filter, and dry the filter cake. The purity of the obtained tipiracil hydrochloride crystals is 99.9%, the impurity TPI-ketone content is 0.01%, and the impurity 2-IP is not detected.

[0050] Experimental Example 2

[0051] Add 200g purified water and 50g crude tipiracil hydrochloride to a 1L reaction bottle, heat to 46°C, stir to dissolve, add 50g isopropanol and 50g ethanol, cool to 43°C in the first stage at a cooling rate of 5-10°C / h, add tipiracil hydrochloride seed crystals, keep warm and stir for 1.5h, cool to 32°C in the second stage at a cooling rate of 5-10°C / h, keep warm and stir for 3h, cool to 5°C in the third stage at a cooling rate of 5-10°C / h, keep warm and stir for 5h, filter, and dry the filter cake. The purity of the tipiracil hydrochloride crystals obtained is 99.9%, the impurity TPI-ketone content is 0.02%, and the impurity 2-IP is not detected.

[0052] Experimental Example 3

[0053] To a 1L reaction bottle, add 200g purified water and 26g crude tipiracil hydrochloride, heat to 47°C, stir to dissolve, add 52g isopropanol, cool to 43°C at a first-stage cooling rate of 5-10°C / h, add tipiracil hydrochloride seed crystals, keep warm and stir for 2h, cool to 30°C at a second-stage cooling rate of 5-10°C / h, keep warm and stir for 3h, cool to 3°C at a third-stage cooling rate of 5-10°C / h, keep warm and stir for 3.5h, filter, and dry the filter cake. The purity of the tipiracil hydrochloride crystals obtained is 99.9%, the impurity TPI-ketone content is 0.01%, and the impurity 2-IP is not detected.

[0054] Experimental Example 4

[0055] To a 1L reaction bottle, 175g of purified water and 35g of crude tipiracil hydrochloride were added, heated to 47°C, stirred to dissolve, 72g of isopropanol was added, and the temperature was cooled to 43°C at a first-stage cooling rate of 5-10°C / h. Tipiracil hydrochloride seed crystals were added, and the mixture was kept warm and stirred for 1.5h. The temperature was cooled to 33°C at a second-stage cooling rate of 5-10°C / h, and the mixture was kept warm and stirred for 3h. The temperature was cooled to 3°C at a third-stage cooling rate of 5-10°C / h, and the mixture was kept warm and stirred for 4h. The mixture was filtered, and the purity of the tipiracil hydrochloride crystals obtained after filter cake drying was 99.9%, the impurity TPI-ketone content was 0.01%, and the impurity 2-IP was not detected.

[0056] Experimental Example 5

[0057] To a 1L reaction bottle, 342g of purified water and 85g of crude tipiracil hydrochloride were added, heated to 48°C, stirred to dissolve, 170g of isopropanol was added, and the temperature was cooled to 40°C in the first stage at a cooling rate of 5-10°C / h. Tipiracil hydrochloride seed crystals were added, and the mixture was kept warm and stirred for 1h. The temperature was cooled to 32°C in the second stage at a cooling rate of 5-10°C / h, and the mixture was kept warm and stirred for 4h. The temperature was cooled to 3°C in the third stage at a cooling rate of 5-10°C / h, and the mixture was kept warm and stirred for 4h. The mixture was filtered, and the purity of the tipiracil hydrochloride crystals obtained after filter cake drying was 99.9%, the impurity TPI-ketone content was 0.02%, and the impurity 2-IP was not detected.

[0058] Experimental Example 6

[0059] To a 100L enameled reactor, 24.20kg of purified water and 6.05kg of crude thiabendazole hydrochloride were added, heated to 46°C, stirred to dissolve, 12.10kg of isopropanol was added, and the temperature was cooled to 42°C in the first stage at a cooling rate of 5-10°C / h. The thiabendazole hydrochloride seed crystals were added, and the mixture was kept warm and stirred for 2h. The temperature was cooled to 31°C in the second stage at a cooling rate of 5-10°C / h, and the mixture was kept warm and stirred for 3h. The temperature was cooled to 4°C in the third stage at a cooling rate of 5-10°C / h, and the mixture was kept warm and stirred for 5h. The mixture was filtered, and the purity of the thiabendazole hydrochloride crystals obtained after filter cake drying was 99.9%, the impurity TPI-ketone content was 0.02%, and the impurity 2-IP was not detected.

[0060] Experimental Example 7

[0061] To a 500 ml reaction bottle, 60 g of purified water and 15 g of crude tipiracil hydrochloride were added, heated to 55 ° C, stirred to dissolve, 30 g of isopropanol was added, and the temperature was cooled to 42 ° C in the first stage at a cooling rate of 5-10 ° C / h, and tipiracil hydrochloride seed crystals were added. The mixture was kept warm and stirred for 1.5 h, and the temperature was cooled to 32 ° C in the second stage at a cooling rate of 5-10 ° C / h. The mixture was kept warm and stirred for 3 h, and the temperature was cooled to 4 ° C in the third stage at a cooling rate of 5-10 ° C / h. The mixture was filtered, and the purity of the tipiracil hydrochloride crystals obtained after the filter cake was dried was 99.8%, the impurity TPI-ketone content was 0.11%, and the impurity 2-IP was not detected.

[0062] Experimental Example 8

[0063] To a 500 ml reaction bottle, 177 g of purified water and 17 g of crude tipiracil hydrochloride were added, heated to 47 ° C, stirred to dissolve, 34 g of isopropanol was added, and the temperature was cooled to 43 ° C in the first stage at a cooling rate of 5-10 ° C / h. Tipiracil hydrochloride seed crystals were added, and the mixture was kept warm and stirred for 2 h. The temperature was cooled to 33 ° C in the second stage at a cooling rate of 5-10 ° C / h, and the temperature was kept warm and stirred for 3 h. The temperature was cooled to 4 ° C in the third stage at a cooling rate of 5-10 ° C / h, and the mixture was kept warm and stirred for 5 h. Filter, dry the filter cake, and obtain 13 g of tipiracil hydrochloride crystals with a yield of 76%, a purity of 99.9%, and impurity TPI-ketone was not detected, and impurity 2-IP was not detected.

[0064] Experimental Example 9

[0065] To a 500 ml reaction bottle, add 60 g of purified water and 15 g of crude tipiracil hydrochloride, heat to 47 ° C, stir to dissolve, add 60 g of isopropanol, cool to 42 ° C at a first-stage cooling rate of 5-10 ° C / h, add tipiracil hydrochloride seed crystals, keep warm and stir for 1.5 h, cool to 32 ° C at a second-stage cooling rate of 5-10 ° C / h, keep warm and stir for 3 h, cool to 4 ° C at a third-stage cooling rate of 5-10 ° C / h, keep warm and stir for 4 h, filter, and dry the filter cake. The purity of the obtained tipiracil hydrochloride crystals is 99.8%, the impurity TPI-ketone content is 0.13%, and the impurity 2-IP content is 0.01%.

[0066] Experimental Example 10

[0067] Add 60g purified water and 15g crude tipiracil hydrochloride to a 500ml reaction bottle, heat to 40°C, stir to dissolve, add 30g isopropanol, solid precipitates quickly, keep warm and stir for 1.5h, cool to 32°C at a cooling rate of 5-10°C / h, keep warm and stir for 3h, cool to 4°C at a cooling rate of 5-10°C / h, keep warm and stir for 5h, filter difficult, the purity of the obtained tipiracil hydrochloride crystals after filter cake drying is 99.8%, the impurity TPI-ketone content is 0.11%, and the impurity 2-IP content is 0.02%.

[0068] Experimental Example 11

[0069] Add 60g purified water and 15g crude tipiracil hydrochloride to a 500ml reaction bottle, heat to 47°C, stir to dissolve, add 30g isopropanol, cool to 35°C, solid precipitates quickly, keep warm and stir for 1.5h, cool to 20°C at a cooling rate of 5-10°C / h, keep warm and stir for 3h, cool to 4°C at a cooling rate of 5-10°C / h, keep warm and stir for 5h, filter difficult, the purity of the obtained tipiracil hydrochloride crystals after filter cake drying is 99.8%, the impurity TPI-ketone content is 0.10%, and the impurity 2-IP content is 0.01%.

[0070] Experimental Example 12

[0071] To a 500 ml reaction bottle, 60 g of purified water and 15 g of crude tipiracil hydrochloride were added, heated to 49 ° C, stirred to dissolve, 30 g of isopropanol was added, and the temperature was cooled to 47 ° C at a first-stage program at a cooling rate of 5-10 ° C / h. Tipiracil hydrochloride seed crystals were added, and the mixture was kept warm and stirred for 1.5 h. The temperature was cooled to 41 ° C at a second-stage program at a cooling rate of 5-10 ° C / h. The mixture was kept warm and stirred for 4 h. The temperature was cooled to 10 ° C at a third-stage program at a cooling rate of 5-10 ° C / h. Solids precipitated rapidly during the cooling process. The mixture was kept warm and stirred for 4 h. The mixture was filtered. The purity of the tipiracil hydrochloride crystals obtained after the filter cake was dried was 99.8%, the impurity TPI-ketone content was 0.06%, and the impurity 2-IP was not detected.

[0072] Comparative Example 1

[0073] Add 20 g crude tipiracil hydrochloride, 240 g isopropanol, and 60 g purified water to a 1 L reaction bottle, stir, heat to 50 ° C, cool to 15 ° C within 2 h, keep stirring for 2 h, filter, and dry the filter cake. The purity of the obtained tipiracil hydrochloride crystals is 99.8%, the impurity TPI-ketone content is 0.16%, and the impurity 2-IP content is 0.03%.

[0074] The embodiments described above are part of the embodiments of the present invention, rather than all of the embodiments. The detailed description of the embodiments of the present invention is not intended to limit the scope of the invention claimed for protection, but merely represents selected embodiments of the present invention. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

Claims

1. A method for preparing tipiradine hydrochloride crystals, characterized in that: The following steps are involved: (1) adding crude tipiracil hydrochloride to water, heating and stirring the water to dissolve; (2) controlling the temperature, adding a certain amount of organic solvent, and then cooling in three stages, and keeping the temperature and stirring after cooling to a certain temperature in each stage; (3) Filter and dry the filter cake to obtain tipiracil hydrochloride crystals.

2. The method according to claim 1, characterized in that The dissolving temperature of the step (1) in water during heating and stirring is 40-55°C, preferably 45-50°C.

3. The method according to claim 1, characterized in that The organic solvent in step (2) is selected from alcohol solvents such as isopropanol, ethanol, methanol and mixtures thereof, preferably isopropanol and ethanol.

4. The method according to any one of claims 1 to 3, characterized in that The weight ratio of the organic solvent in step (2) to the water in step (1) is 1:(1-5), preferably 1:(2-4).

5. The method according to any one of claims 1 to 4, characterized in that The cooling rate of the three-stage programmed cooling in step (2) is 5-10°C / h.

6. The method according to any one of claims 1 to 6, characterized in that In the first stage of step (2), the temperature is lowered to 35-50° C., preferably 40-45° C., and after adding the tipiracil hydrochloride seed crystals, the stirring time is kept at this temperature for 1-2 hours.

7. The method according to any one of claims 1 to 7, characterized in that In the second stage of step (2), the temperature is lowered to 20-40°C, preferably 30-35°C, and stirred for 3-4 hours.

8. The method according to any one of claims 1 to 8, characterized in that In the third stage of step (2), the temperature is lowered to 0-10°C, preferably 0-5°C, and stirred for 3-5 hours.

9. The method according to any one of claims 1 to 8, characterized in that The TPI-ketone impurity content in the tipiracil hydrochloride crystals obtained by filtration and drying in step (3) is not higher than 0.15%, preferably not higher than 0.02%, and the 2-IP impurity content is not higher than 0.02%, preferably not higher than 0.003%.

10. A method for reducing the content of related impurities in tipiracil hydrochloride crystals, characterized in that: The following steps are involved: (1) adding crude tipiracil hydrochloride to water, heating and stirring the water to dissolve; (2) controlling the temperature, adding a certain amount of organic solvent, and then cooling in three stages, and keeping the temperature and stirring after cooling to a certain temperature in each stage; (3) Filter and dry the filter cake to obtain tipiracil hydrochloride crystals.